Electroacupuncture Analgesia for Colonoscopy
1 other identifier
interventional
128
1 country
1
Brief Summary
Background: Colonoscopy is often regarded as a painful and unpleasant procedure. Electroacupuncture (EA) has been used successfully to treat pain of various origins, but few good-quality studies have evaluated its role in treating pain and anxiety during colonoscopy. Objective: To investigate the efficacy of EA in reducing procedure-related pain and the consumption of sedatives/analgesics during colonoscopy. Design: Prospective, randomized, double-blind, sham-controlled study. Subjects: One hundred and twenty eight consecutive patients undergoing first-time elective day-case colonoscopy without previous experience of acupuncture will be recruited. Interventions: Patients will be randomized to receive either 45 minutes of EA or sham acupuncture (SA) before colonoscopy. The acupoints relevant to the treatment of abdominal pain, including Zusanli, Hegu, and Neiguan will be used. For the SA group, blunt-tip needles will be placed (without skin penetration) 15 mm away from the acupoints. Foam blocks will be used to stabilize the needles and to blind the patients and endoscopists to the treatment allocation. EA and SA will be continued throughout colonoscopy. A mixture of Propofol and Alfentanil, delivered by a patient-controlled syringe pump, will be used for sedation/analgesia in both groups. Outcome measures: Primary outcome: doses of patient-controlled sedation/analgesia consumed. Secondary outcomes: pain and satisfaction scores according to a visual analog scale, cecal intubation rate/time, and episodes of hypotension/desaturation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3 pain
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 6, 2011
CompletedFirst Posted
Study publicly available on registry
June 8, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedDecember 17, 2012
December 1, 2012
1 year
June 6, 2011
December 14, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Dose of patient-controlled sedation/analgesia consumed
During the procedure (up to 1 day)
Secondary Outcomes (9)
Pain score
During the procedure (up to 1 day)
Patients' satisfaction score
During the procedure (up to 1 day)
Patients' willingness to repeat the procedure
Up to 1 day
Endoscopists' satisfaction score
During the procedure (up to 1 day)
Cecal intubation rate
During the procedure (up to 1 day)
- +4 more secondary outcomes
Study Arms (2)
Electroacupuncture
EXPERIMENTALSham acupuncture
ACTIVE COMPARATORInterventions
Patients randomized to the experimental group will receive electroacupuncture at acupoints relevant to the treatment of abdominal pain and anxiety, including Zusanli (stomach meridian ST-36), Hegu (large intestine meridian LI-4), and Neiguan (pericardium meridian PC-6). Electric stimulation will be employed to the needles
Sterile blunt-tip needles will be placed (without skin penetration) 15 mm away from the acupoints. "Pseudostimulation" will be given by deliberately connecting the needle to the incorrect output socket of the electroacupuncture device, thus there will be no flow of electric current.
Eligibility Criteria
You may qualify if:
- Consecutive patients (aged between 18 and 60 years) undergoing first-time elective day-case colonoscopy
- Patients with American Society of Anesthesiologists (ASA) grading I-II
- Informed consent available
You may not qualify if:
- Patients with previous experience of acupuncture
- Patients with previous history of colorectal surgery
- Patients who are diagnosed with irritable bowel syndrome according to Rome III criteria
- Patients with chronic pain syndrome
- Patients with psychiatric disorder
- Patients with poor cognitive function
- Patients with renal impairment
- Patients with obstructive sleep apnea syndrome
- Patients with cardiac arrhythmias
- Patients with cardiac pacemaker
- Patients who are pregnant
- Patients who are allergic to the acupuncture needles or Propofol/Alfentanil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Prince of Wales Hospital, The Chinese University of Hong Kong
Hong Kong SAR, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Simon SM Ng, MD
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 6, 2011
First Posted
June 8, 2011
Study Start
October 1, 2011
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
December 17, 2012
Record last verified: 2012-12